3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Kaposi
2
Sarcoma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Hemangioma, Capillary
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Ulcer
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Lymphatic Metastasis
1
Liver Neoplasms
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
69
Nivolumab
67
cabozantinib
45
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
32
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
17
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Propranolol
×
1 year
×
Clear all
No trials found.